Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · LeMaitre Vascular (LMAT)

LeMaitre Vascular CFO Joseph Pellegrino to retire March 2025; reaffirms guidance

Neutral Impact 4 of 5 leadership Written later

LeMaitre Vascular said Chief Financial Officer Joseph P. Pellegrino Jr. will retire as an employee effective March 7, 2025, after the anticipated filing of the 2024 Form 10-K, and will remain on the Board of Directors. The company will search for a replacement CFO and expects Pellegrino to take part in the hiring process. The company also reaffirmed its August 1, 2024 financial guidance for Q3 and full-year 2024 as of August 26, 2024.

Key points

  • Pellegrino retires as an employee, including as CFO, effective March 7, 2025
  • He remains on the Board, serving out his term until June 2027 after being re-elected in June 2024
  • The company thanks him for 19 years of executive service and will search for a replacement CFO
  • Guidance from August 1, 2024 for Q3 2024 and Full-Year 2024 was reaffirmed as of August 26, 2024

The filing

CompanyLeMaitre Vascular (LMAT)
Form8-K, current report
Filed with the SECAug 26, 2024, 4:12 PM ET
Accession number0001437749-24-027754

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 26, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.